Accumulating evidence has elucidated the role of KDM1A in chondrocytes, positioning it as a potential therapeutic target for OA and other arthritic conditions as a potential target for the treatment of OA and other arthritis. This evidence concerns the gene KDM1A and arthritic joint disease.